Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

1341 results about "Body compartment" patented technology

Intelligent door control system of rail train

The invention discloses an intelligent door control system of a rail train, which comprises control modules, driving modules and a monitoring and diagnosing module, wherein each carriage is controlled by a control module, a driving module is arranged on each door, and in each carriage, the control module and the driving modules are communicated by adopting a CAN (controller area network) bus so as to realize a control mode where one control module corresponds to multiple driving modules. The control modules are connected with a train bus. The operation processes are as follows: the control modules receive control signals such as door opening, door closing and the like transmitted on the train bus, send TCMS (train control and monitor system) communication commands to the driving module on each door by the CAN bus or in other communication manners according to the obtained control signals so as to control opening and closing actions of the doors by electric motors, and carry out collection and tentative diagnosis on real-time monitoring data of the driving modules on the electric motors. The intelligent door control system can carry out real-time monitoring and diagnosis on running states of the control modules, the driving modules and the electric motors, so as to estimate safety degree of a door system and improve running reliability of a train.
Owner:NANJING UNIV OF SCI & TECH

Stabilized reverse micelle compositions and uses thereof

The invention relates to compositions and methods for drug delivery suitable for promoting the transmucosal absorption of drugs, especially drugs with poor intrinsic bioavailability, such as peptides, proteins, vaccines, and nucleic acids. The delivery system of this invention preferably comprises fatty acid esters and their hydrophilic derivatives that associate with water and other polar solvents to form reverse micelles tha are physically stabilized in the presence of gastrointestinal fluid, water, and other hydrophilic solvents. Such stable reverse micelles are formed by suitable mixtures of polymeric or non-polymeric compounds with amphiphiles. Micelles made using these methods undergo phase transformation more slowly resulting in delayed drug release profiles and sustained absorption. When administered as a pharmaceutical to mucosal surfaces following oral ingestion or intranasal administration, therapeutic molecules principally solubilized in the aqueous phase are protected from digestion by mucosal enzymes and other mucosal degradative processes and are taken up by absorptive cell mechanisms and reach appropriate body compartments. The reverse micelle compositions may comprise mono-, di-glycerides and/or their transesterifed products containing C6-C12 fatty acids chains, wherein the transester groups consist of hydrohilic moieties.
Owner:SOLIGENIX INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products